Injection Drug Use-Associated HIV, HCV Risk Higher in Women, Younger Individuals
Researchers evaluated global data on HIV infection and primary hepatic C virus infection incidence among injections drug users.
Researchers evaluated global data on HIV infection and primary hepatic C virus infection incidence among injections drug users.
All DEA-registered clinicians must meet a one-time, 8-hour training requirement for opioid or other substance use disorder. Learn whether your past training meets the requirement.
Using a tetherless, adhesive fingertip sensor, the device monitors several physiological markers to detect the impairment of oxygenation due to opioid use.
We interviewed Anna Lembke, MD, about her book Dopamine Nation: Finding Balance in the Age of Indulgence.
AANP and AAPA Presidents discuss how elimination of the X-Waiver and patient caps for buprenorphine prescription for opioid use disorder will affect clinical practice.
A 45-year-old man presents to his primary care office at 9:00 AM after he was asked to leave work the day before because he smelled of alcohol and had been acting erratically.
Innovative program helps manage stimulant use disorder and provides PrEP services and treatment to patients at risk for and living with HIV.
Jim Anderson, MPAS, PA-C, wonders if SAMHSA will make the methadone take-home flexibility program permanent.
Determining when smartphone use has become an addiction in patients is tricky. Researchers outline what to look for.
Resource provides detailed information on simple screening and assessment tools, evidence-based treatment options, counseling, and referrals.